Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CODX Co-Diagnostics Inc
- Stocks
- Healthcare
- NASDAQ: CODX
Price (delayed)
$0.2887
Market cap
$9.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.17
Enterprise value
$9.76M
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using
Highlights
Co-Diagnostics's gross margin has surged by 88% YoY and by 4% QoQ
The company's debt fell by 31% YoY and by 10% QoQ
Co-Diagnostics's quick ratio has shrunk by 58% YoY
The revenue has contracted by 48% YoY and by 11% from the previous quarter
Key stats
What are the main financial stats of CODX
Market
Valuations
Earnings
Shares outstanding
33.71M
Market cap
$9.73M
Enterprise value
$9.76M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.2
Price to sales (P/S)
2.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.79
Revenue
$3.5M
Gross profit
$2.71M
Operating income
-$38.37M
Net income
-$35.86M
EBIT
-$35.81M
EBITDA
-$34.48M
Free cash flow
-$29.85M
Per share
Balance sheet
Liquidity
EPS
-$1.17
EPS diluted
-$1.17
Free cash flow per share
-$0.93
Book value per share
$1.43
Revenue per share
$0.11
TBVPS
$0.91
Total assets
$55.15M
Total liabilities
$7.23M
Debt
$1.93M
Equity
$47.92M
Working capital
$18.45M
Debt to equity
0.04
Current ratio
4.43
Quick ratio
4.02
Net debt/EBITDA
0
Margins
Efficiency
Dividend
EBITDA margin
-985.9%
Gross margin
77.5%
Net margin
-1,025.3%
Operating margin
-1,097.2%
Return on assets
-52.7%
Return on equity
-60.2%
Return on invested capital
-116.1%
Return on capital employed
-72%
Return on sales
-1,024%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CODX stock price
How has the Co-Diagnostics stock price performed over time
Intraday
1.76%
1 week
-0.45%
1 month
-21.53%
1 year
-72.76%
YTD
-61.51%
QTD
-6.75%
Financial performance
How have Co-Diagnostics's revenue and profit performed over time
Revenue
$3.5M
Gross profit
$2.71M
Operating income
-$38.37M
Net income
-$35.86M
Gross margin
77.5%
Net margin
-1,025.3%
Co-Diagnostics's gross margin has surged by 88% YoY and by 4% QoQ
The company's net margin has shrunk by 76% YoY and by 7% QoQ
Co-Diagnostics's operating margin has plunged by 70% YoY and by 7% from the previous quarter
The revenue has contracted by 48% YoY and by 11% from the previous quarter
Price vs fundamentals
How does CODX's price correlate with its fundamentals
Growth
What is Co-Diagnostics's growth rate over time
Valuation
What is Co-Diagnostics stock price valuation
P/E
N/A
P/B
0.2
P/S
2.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.79
CODX's EPS is up by 11% year-on-year and by 6% since the previous quarter
The P/B is 91% below the 5-year quarterly average of 2.3 and 60% below the last 4 quarters average of 0.5
The equity has declined by 39% year-on-year and by 12% since the previous quarter
The revenue has contracted by 48% YoY and by 11% from the previous quarter
The P/S is 45% below the 5-year quarterly average of 4.7 and 42% below the last 4 quarters average of 4.5
Efficiency
How efficient is Co-Diagnostics business performance
CODX's return on sales has dropped by 74% year-on-year and by 7% since the previous quarter
CODX's return on invested capital has dropped by 67% year-on-year and by 3.8% since the previous quarter
CODX's return on equity is down by 42% year-on-year and by 8% since the previous quarter
The ROA has contracted by 37% YoY and by 6% from the previous quarter
Dividends
What is CODX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CODX.
Financial health
How did Co-Diagnostics financials performed over time
Co-Diagnostics's quick ratio has shrunk by 58% YoY
The current ratio has plunged by 57% YoY
The company's debt is 96% lower than its equity
The equity has declined by 39% year-on-year and by 12% since the previous quarter
The company's debt fell by 31% YoY and by 10% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.